Institute of Biomedical Research Corp.

OTCPK:MRES Stock Report

Market Cap: US$36.9m

Institute of Biomedical Research Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Drasko Pekovic

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure15yrs
CEO ownershipn/a
Management average tenure9.4yrs
Board average tenure9.4yrs

Recent management updates

Recent updates

CEO

Drasko Pekovic

15yrs

Tenure

Dr. Drasko D. Pekovic founded Institute of Biomedical Research Corp. in 2010 and serves as its Chief Executive Officer and President. Dr. Pekovic has been the Chairman of the Board of Institute of Biomedic...

Leadership Team

NamePositionTenureCompensationOwnership
Drasko Pekovic
Founder15yrsno datano data
Victor Lange
Chief Executive Officer of M2MMA1.3yrsno datano data
Teodor Burtea
Director & Member of Scientific Council9.4yrsno datano data

9.4yrs

Average Tenure

Experienced Management: MRES's management team is seasoned and experienced (9.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Drasko Pekovic
Founder9.4yrsno datano data
Teodor Burtea
Director & Member of Scientific Council9.4yrsno datano data
Perko Vukotic
Deputy Chairman9.4yrsno datano data
Maihailo Buric
Director9.4yrsno datano data
Goran Jovetic
Director9.4yrsno datano data
Zoran Vratnica
Director9.4yrsno datano data
Zeljko Jacimovic
Member of Scientific Council9.4yrsno datano data
Aleksandar Joksimovic
Member of Scientific Council9.4yrsno datano data
Momir Mikov
Member of Scientific Council9.4yrsno datano data
Richard Morisset
Member of Scientific Council9.4yrsno datano data
Boban Mugosa
Member of Scientific Council9.4yrsno datano data
Ivan Popovic
Member of Scientific Council9.4yrsno datano data

9.4yrs

Average Tenure

Experienced Board: MRES's board of directors are considered experienced (9.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 01:22
End of Day Share Price 2025/01/10 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Institute of Biomedical Research Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution